Table. 1.

Patient details of the entire cohort

Bile leak (n = 146) No bile leak (n = 716) p-value
Age (yr) 53 (44–62) 55 (43–63) 0.399
Sex 0.266
Male 89 (61.0) 471 (65.8)
Female 57 (39.0) 245 (34.2)
ASA 0.431
1 85 (58.2) 379 (53.0)
2 53 (36.3) 302 (42.1)
3 8 (5.5) 35 (4.9)
BMI (kg/m2) 22.8 (20.2–25.2) 23.4 (21.0–26.0) 0.126
Preoperative jaundice 0.003
Yes 13 (8.9) 24 (3.4)
No 133 (91.1) 692 (96.6)
Serum albumin (g/dL) 4 (3.7–4.2) 4 (3.7–4.3) 0.160
Hb (g/dL) 12.1 (10.9–13.2) 12.1 (11.0–13.2) 0.947
Preoperative biliary drainage < 0.001
Yes 16 (11.0) 23 (3.2)
No 130 (89.0) 693 (96.8)
Diagnosis < 0.001
Hepatocellular cancer 47 (32.2) 259 (36.2)
Metastatic colorectal cancer 22 (15.1) 190 (26.5)
Cholangiocarcinoma 34 (23.3) 77 (10.7)
Other metastatic cancers 28 (19.2) 130 (18.1)
Benign histology 15 (10.3) 60 (8.4)

Values are presented as median (interquartile range) or number (%).

ASA, American Society of Anaesthesiologists Physical Status Classification System; BMI, body mass index; Hb, hemoglobin.

Ann Hepatobiliary Pancreat Surg 2024;28:451-7 https://doi.org/10.14701/ahbps.24-078
© 2024 Ann Hepatobiliary Pancreat Surg